Profund Advisors LLC Regeneron Pharmaceuticals, Inc. Transaction History

Profund Advisors LLC

  • $2.59 Billion
  • Q3 2024

A detailed history of Profund Advisors LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Profund Advisors LLC holds 11,703 shares of REGN stock, worth $8.22 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares
11,703
Previous 12,669 7.62%
Holding current value
$8.22 Million
Previous $13.3 Million 7.61%
% of portfolio
0.47%
Previous 0.5%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$1024.09 - $1201.76 $989,270 - $1.16 Million
-966 Reduced 7.62%
11,703 $12.3 Million
Q2 2024

Aug 13, 2024
BUY
$883.2 - $1071.19 $1.47 Million - $1.78 Million
1,663 Added 15.11%
12,669 $13.3 Million
Q1 2024

May 08, 2024
SELL
$902.69 - $993.35 $616,537 - $678,458
-683 Reduced 5.84%
11,006 $10.6 Million
Q4 2023

Feb 14, 2024
BUY
$775.18 - $881.7 $1.18 Million - $1.34 Million
1,523 Added 14.98%
11,689 $10.3 Million
Q3 2023

Nov 13, 2023
BUY
$692.45 - $844.37 $1.17 Million - $1.43 Million
1,689 Added 19.92%
10,166 $8.37 Million
Q2 2023

Aug 10, 2023
BUY
$700.03 - $830.35 $483,720 - $573,771
691 Added 8.87%
8,477 $6.09 Million
Q1 2023

May 11, 2023
SELL
$680.49 - $826.97 $6.42 Million - $7.8 Million
-9,430 Reduced 54.77%
7,786 $6.4 Million
Q4 2022

Feb 02, 2023
SELL
$705.89 - $766.39 $45,882 - $49,815
-65 Reduced 0.38%
17,216 $12.4 Million
Q3 2022

Nov 04, 2022
SELL
$573.97 - $724.32 $586,597 - $740,255
-1,022 Reduced 5.58%
17,281 $11.9 Million
Q2 2022

Aug 01, 2022
SELL
$548.35 - $738.84 $1.13 Million - $1.52 Million
-2,059 Reduced 10.11%
18,303 $10.8 Million
Q1 2022

May 10, 2022
SELL
$595.12 - $698.43 $2.46 Million - $2.88 Million
-4,130 Reduced 16.86%
20,362 $14.2 Million
Q4 2021

Feb 08, 2022
SELL
$543.48 - $670.97 $1.49 Million - $1.84 Million
-2,742 Reduced 10.07%
24,492 $15.5 Million
Q3 2021

Nov 12, 2021
BUY
$574.03 - $680.96 $35,015 - $41,538
61 Added 0.22%
27,234 $16.5 Million
Q2 2021

Aug 12, 2021
SELL
$472.8 - $558.54 $440,649 - $520,559
-932 Reduced 3.32%
27,173 $15.2 Million
Q1 2021

May 14, 2021
SELL
$446.73 - $548.2 $303,776 - $372,776
-680 Reduced 2.36%
28,105 $13.3 Million
Q4 2020

Feb 09, 2021
BUY
$478.3 - $607.98 $1.12 Million - $1.42 Million
2,332 Added 8.82%
28,785 $13.9 Million
Q3 2020

Nov 13, 2020
SELL
$544.75 - $658.21 $1.34 Million - $1.62 Million
-2,457 Reduced 8.5%
26,453 $14.8 Million
Q2 2020

Aug 03, 2020
BUY
$493.32 - $643.92 $3.63 Million - $4.74 Million
7,356 Added 34.13%
28,910 $18 Million
Q1 2020

May 15, 2020
SELL
$336.18 - $494.43 $2.35 Million - $3.46 Million
-7,004 Reduced 24.53%
21,554 $10.5 Million
Q4 2019

Feb 18, 2020
BUY
$274.13 - $376.51 $799,637 - $1.1 Million
2,917 Added 11.38%
28,558 $10.7 Million
Q3 2019

Nov 12, 2019
SELL
$273.46 - $318.39 $270,998 - $315,524
-991 Reduced 3.72%
25,641 $7.11 Million
Q2 2019

Aug 13, 2019
SELL
$299.6 - $414.82 $507,822 - $703,119
-1,695 Reduced 5.98%
26,632 $8.34 Million
Q1 2019

May 15, 2019
BUY
$372.08 - $439.57 $240,735 - $284,401
647 Added 2.34%
28,327 $11.6 Million
Q4 2018

Feb 14, 2019
SELL
$335.82 - $403.04 $2.21 Million - $2.66 Million
-6,593 Reduced 19.24%
27,680 $10.3 Million
Q3 2018

Nov 13, 2018
BUY
$351.14 - $408.51 $1.02 Million - $1.19 Million
2,910 Added 9.28%
34,273 $13.8 Million
Q2 2018

Aug 13, 2018
SELL
$284.6 - $344.99 $417,792 - $506,445
-1,468 Reduced 4.47%
31,363 $10.8 Million
Q1 2018

May 14, 2018
SELL
$315.82 - $393.78 $693,224 - $864,347
-2,195 Reduced 6.27%
32,831 $11.3 Million
Q4 2017

Feb 14, 2018
SELL
$358.63 - $469.95 $1.26 Million - $1.65 Million
-3,506 Reduced 9.1%
35,026 $13.2 Million
Q3 2017

Nov 13, 2017
BUY
$431.38 - $504.0 $1.35 Million - $1.57 Million
3,119 Added 8.81%
38,532 $17.2 Million
Q2 2017

Aug 11, 2017
BUY
N/A
35,413
35,413 $17.4 Million

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email